Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma

Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma

Abstract Background We investigated whether adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers affected survival of patients with the early stage of large‐cell neuroendocrine cancer. Methods This was a retrospective multicenter study including consecutive patie...

Descrición completa

Detalles Bibliográficos
Main Authors: Claudio Andreetti, Mohsen Ibrahim, Antonio Gagliardi, Camilla Poggi, Giulio Maurizi, Domenico Armillotta, Valentina Peritone, Leonardo Teodonio, Erino Angelo Rendina, Federico Venuta, Marco Anile, Giovanni Natale, Mario Santini, Alfonso Fiorelli
Formato: Artigo
Idioma:English
Publicado: Wiley 2022-04-01
Series:Thoracic Cancer
Subjects:
adjuvant chemotherapy
immunoistochemical neuroendocrine markers
large‐cell neuroendocrine carcinoma
lobectomy
surgery
Acceso en liña:https://doi.org/10.1111/1759-7714.14287

Internet

https://doi.org/10.1111/1759-7714.14287

Títulos similares